Open AccessPARP inhibitors in breast and ovarian cancer with BRCA mutations: a meta-analysis of survival
Author(s) -
Fengping Shao,
Yaoyun Duan,
Yunhe Zhao,
Yinguang Li,
Jun Li,
Cai Zhang,
Shanyang He
Publication year - 2021
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.202724
Subject(s) - ovarian cancer , brca mutation , oncology , breast cancer , medicine , meta analysis , poly adp ribose polymerase , parp inhibitor , olaparib , cancer , cancer research , biology , genetics , polymerase , gene
To evaluate the efficacy of poly ADP ribose polymerase (PARP) inhibitors (PARPis) in breast and ovarian cancer with BRCA (BReast CAncer susceptibility gene) mutation (BRCAm).